The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies

• Hermann Einsele,
• Javier Briones,
• Fabio Ciceri,
• Irene García Cadenas,
• Fred Falkenburg,
• Natacha Bolaños,
• H.M. Mirjam Heemskerk,
• Roch Houot,
• Michael Hudecek,
• Franco Locatelli,
• Kate Morgan,
• Emma C. Morris,
• Michael O’Dwyer,
• Jordi Gil Sierra,
• Marcel van den Brink,
• Arjan A. van de Loosdrecht

Affiliations

Hermann Einsele

1 Department of Internal Medicine II, University Hospital Würzburg, Germany

Javier Briones

2 Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Fabio Ciceri

3 Department Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy

Irene García Cadenas

2 Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Fred Falkenburg

4 Department of Hematology, Leiden University Medical Center, The Netherlands

Natacha Bolaños

5 Lymphoma Coalition Europe, Paris, France

H.M. Mirjam Heemskerk

4 Department of Hematology, Leiden University Medical Center, The Netherlands

Roch Houot

6 CHU Rennes, University of Rennes, INSERM U1236, France

Michael Hudecek

1 Department of Internal Medicine II, University Hospital Würzburg, Germany

Franco Locatelli

7 La Sapienza, University of Rome, Italy

Kate Morgan

9 Myeloma Patients Europe, Brussels, Belgium

Emma C. Morris

10 University College London, United Kingdom

Michael O’Dwyer

11 National University of Ireland, Galway, Ireland

Jordi Gil Sierra

2 Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Marcel van den Brink

12 Memorial Sloan-Kettering Cancer Center and Sloan Kettering Institute, New York, NY, USA

Arjan A. van de Loosdrecht

14 Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, The Netherlands